The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat.
Open accessAbstract
We have shown that osteogenic protein-1 (OP-1) (bone morphogenetic protein-7) is responsible for the induction of nephrogenic mesenchyme during embryonic kidney development. Gene knock-out studies showed that OP-1 null mutant mice die of renal failure within the first day of postnatal life. In the present study, we evaluated the effect of recombinant human OP-1 for the treatment of acute renal failure after 60 min bilateral renal artery occlusion in rats. Bioavailability studies in normal rats indicate that approximately 1.4 microg OP-1/ml is available in the circulation 1 min after intravenous administration of 250 microg/kg, which then declines steadily with a half life of 30 min. About 0.5% of the administered OP-1 dose/g tissue is targeted for OP-1 receptors in the kidney. We show that OP-1 preserves kidney function, as determined by reduced blood urea nitrogen and serum creatinine, and increased survival rate when administered 10 min before or 1 or 16 h after ischemia, and then at 24-h intervals up to 72 h after reperfusion. Histochemical and molecular analyses demonstrate that OP-1: (a) minimizes infarction and cell necrosis, and decreases the number of plugged tubules; (b) suppresses inflammation by downregulating the expression of intercellular adhesive molecule, and prevents the accumulation and activity of neutrophils; (c) maintains the expression of the vascular smooth muscle cell phenotype in pericellular capillaries; and (d) reduces programmed cell death during the recovery. Collectively, these data suggest that OP-1 prevents the loss of kidney function associated with ischemic injury and may provide a basis for the treatment of acute renal failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Bone: Formation by Autoinduction
Urist, M. R. (1965) · Science · doi:10.1126/science.150.3698.893 · Cited by 5,546
Thadhani, R., Pascual, M., & Bonventre, J. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342207 · Cited by 1,417
A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.
Dudley, A. T., Lyons, K. M., & Robertson, E. J. (1995) · Genes & Development · doi:10.1101/gad.9.22.2795 · Cited by 1,131
Luo, G., Hofmann, C., Bronckers, A. L., Sohocki, M., Bradley, A., & Karsenty, G. (1995) · Genes & Development · doi:10.1101/gad.9.22.2808 · Cited by 1,021
Bone morphogenetic proteins in development
Hogan, B. L. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80064-5 · Cited by 705
Sampath, T. K., Maliakal, J. C., Hauschka, P. V., Jones, W. K., Sasak, H., Tucker, R. F., White, K. H., Coughlin, J. E., Tucker, M. M., & Pang, R. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88709-4 · Cited by 678
Self-citationBone morphogenetic proteins in development
Simic, P., & Vukicevic, S. (2004) · Bone Morphogenetic Proteins: Regeneration of Bone and Beyond · doi:10.1007/978-3-0348-7857-9_4 · Cited by 672
Self-citationWitzgall, R., Brown, D., Schwarz, C., & Bonventre, J. V. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117214 · Cited by 603
Sampath, T. K., & Reddi, A. H. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7599 · Cited by 588
Self-citationMechanisms of ischemic acute renal failure
Bonventre, J. V. (1993) · Kidney International · doi:10.1038/ki.1993.163 · Cited by 516
Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury.
Kelly, K. J., Williams, W. W., Colvin, R. B., & Bonventre, J. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.812 · Cited by 489
Humes, H. D., Cieslinski, D. A., Coimbra, T. M., Messana, J. M., & Galvao, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114359 · Cited by 407
Bone: Formation by Autoinduction
Urist, M. R., & Peltier, L. F. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200202000-00002 · Cited by 279
Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats.
Chiao, H., Kohda, Y., McLeroy, P., Craig, L., Housini, I., & Star, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119272 · Cited by 279
Postischemic renal injury is mediated by neutrophils and leukotrienes
Klausner, J. M., Paterson, I. S., Goldman, G., Kobzik, L., Rodzen, C., Lawrence, R., Valeri, C. R., Shepro, D., & Hechtman, H. B. (1989) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1989.256.5.f794 · Cited by 209
Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats
Miller, S. B., Martin, D. R., Kissane, J., & Hammerman, M. R. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.1.f129 · Cited by 203
Vukicevic, S., Latin, V., Chen, P., Batorsky, R., Reddi, A. H., & Sampath, T. K. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1100 · Cited by 199
Self-citationBrady, H. R., & Singer, G. G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92057-9 · Cited by 176
Racusen, L. C., Fivush, B. A., Yl, L., et al. (1991) · PubMed · Cited by 162
Therapeutic use of growth factors in renal failure.
Hammerman, M. R., & Miller, S. B. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v511 · Cited by 136
Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia
Perides, G., Jensen, F. E., Edgecomb, P., Rueger, D. C., & Charness, M. E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11327-s · Cited by 49
Acute renal failure: prevailing challenges and prospects for the future.
Humes, H. D. (1995) · PubMed · Cited by 48
Growth factors and cytokines in acute renal failure.
Harris, R. C. (1997) · PubMed · Cited by 45
Dattatreyamurty, B., Schneyer, A. L., & Reichert, L. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69277-4 · Cited by 43
Self-citationTrypsin-induced follicular papilla apoptosis results in delayed hair growth and pigmentation
Seiberg, M., Wisniewski, S. R., Cauwenbergh, G. F. M. J., & Shapiro, S. S. (1997) · Developmental Dynamics · Cited by 30
Regulation of transcription by the rat EGF gene promoter in normal and ischemic murine kidney cells
Price, P. M., Megyesi, J. K., Saggi, S. J., & Safirstein, R. L. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.4.f664 · Cited by 24
Cited by
Pathophysiology of Acute Kidney Injury
Basile, D. P., Anderson, M. D., & Sutton, T. A. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110041 · Cited by 1,094
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
Zhang, M., Liu, Q., Meng, H., Duan, H., Liu, X., Wu, J., Gao, F., Wang, S., Tan, R., & Yuan, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01688-x · Cited by 712
Bone morphogenetic proteins in development
Simic, P., & Vukicevic, S. (2004) · Bone Morphogenetic Proteins: Regeneration of Bone and Beyond · doi:10.1007/978-3-0348-7857-9_4 · Cited by 672
Self-citationMaintenance Dialysis Population Dynamics: Current Trends and Long-Term Implications
Lysaght, M. J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13suppl_1s37 · Cited by 609
Katagiri, T., & Watabe, T. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021899 · Cited by 529
Metadata
- Authors
- Vukicevic, S., Basic, V, Rogic, D., Basic, N., Shih, M. S., Shepard, A., Jin, D., Dattatreyamurty, B., Jones, W., Dorai, H., Ryan, S., Griffiths, D., Maliakal, J., Jelic, M., Pastorcic, M., Stavljenic, A., & Sampath, T. K.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-07-01
- Volume
- 102
- Issue
- 1
- Pages
- 202-214
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2036755333
- Cited by
- 327
- References
- 27
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.